581 related articles for article (PubMed ID: 34386902)
1. Association of CNS demyelination and COVID-19 infection: an updated systematic review.
Ismail II; Salama S
J Neurol; 2022 Feb; 269(2):541-576. PubMed ID: 34386902
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of cases of CNS demyelination following COVID-19 vaccination.
Ismail II; Salama S
J Neuroimmunol; 2022 Jan; 362():577765. PubMed ID: 34839149
[TBL] [Abstract][Full Text] [Related]
3. Spinal cord involvement in COVID-19: A review.
Garg RK; Paliwal VK; Gupta A
J Spinal Cord Med; 2023 May; 46(3):390-404. PubMed ID: 33705268
[No Abstract] [Full Text] [Related]
4. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2.
Sriwastava S; Tandon M; Podury S; Prasad A; Wen S; Guthrie G; Kakara M; Jaiswal S; Subedi R; Elkhooly M; Lisak RP
J Neurol; 2021 Dec; 268(12):4448-4478. PubMed ID: 34009454
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and the risk of CNS demyelinating diseases: A systematic review.
Lotan I; Nishiyama S; Manzano GS; Lydston M; Levy M
Front Neurol; 2022; 13():970383. PubMed ID: 36203986
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and emerging spinal cord complications: A systematic review.
Mondal R; Deb S; Shome G; Ganguly U; Lahiri D; Benito-León J
Mult Scler Relat Disord; 2021 Jun; 51():102917. PubMed ID: 33845350
[TBL] [Abstract][Full Text] [Related]
8. New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review.
Harel T; Gorman EF; Wallin MT
Front Neurol; 2023; 14():1099758. PubMed ID: 37426444
[TBL] [Abstract][Full Text] [Related]
9. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
[TBL] [Abstract][Full Text] [Related]
10. Post COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD): A case report-based systematic review.
Mirmosayyeb O; Ghaffary EM; Bagherieh S; Barzegar M; Dehghan MS; Shaygannejad V
Mult Scler Relat Disord; 2022 Apr; 60():103697. PubMed ID: 35306242
[TBL] [Abstract][Full Text] [Related]
11. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
Front Immunol; 2021; 12():653786. PubMed ID: 33981305
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and the Pandemic-Related Aspects in Pediatric Demyelinating Disorders.
Gombolay G; Hallman-Cooper J
Semin Pediatr Neurol; 2023 Jul; 46():101055. PubMed ID: 37451752
[TBL] [Abstract][Full Text] [Related]
13. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.
Pagenkopf C; Südmeyer M
J Neuroimmunol; 2021 Sep; 358():577606. PubMed ID: 34182207
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of cases of acute myelitis in individuals with COVID-19.
Schulte EC; Hauer L; Kunz AB; Sellner J
Eur J Neurol; 2021 Oct; 28(10):3230-3244. PubMed ID: 34060708
[TBL] [Abstract][Full Text] [Related]
15. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review.
Sharifian-Dorche M; Sahraian MA; Fadda G; Osherov M; Sharifian-Dorche A; Karaminia M; Saveriano AW; La Piana R; Antel JP; Giacomini PS
Mult Scler Relat Disord; 2021 May; 50():102800. PubMed ID: 33578206
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD.
Yeo T; Quek AML; Yong KP; Tye JSN; Ratnagopal P; Soon DTL; Tan K
Mult Scler Relat Disord; 2022 Sep; 65():104003. PubMed ID: 35803084
[TBL] [Abstract][Full Text] [Related]
18. A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection.
Ghosh R; De K; Roy D; Mandal A; Biswas S; Biswas S; Sengupta S; Naga D; Ghosh M; Benito-León J
J Neuroimmunol; 2020 Nov; 350():577439. PubMed ID: 33333471
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
Aungsumart S; Apiwattanakul M
Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
[TBL] [Abstract][Full Text] [Related]
20. Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
Lohmann L; Glaser F; Möddel G; Lünemann JD; Wiendl H; Klotz L
BMC Neurol; 2022 May; 22(1):185. PubMed ID: 35585528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
